Marta Jeison

1.1k total citations
20 papers, 345 citations indexed

About

Marta Jeison is a scholar working on Neurology, Hematology and Genetics. According to data from OpenAlex, Marta Jeison has authored 20 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 7 papers in Hematology and 7 papers in Genetics. Recurrent topics in Marta Jeison's work include Neuroblastoma Research and Treatments (8 papers), Acute Myeloid Leukemia Research (7 papers) and Sarcoma Diagnosis and Treatment (4 papers). Marta Jeison is often cited by papers focused on Neuroblastoma Research and Treatments (8 papers), Acute Myeloid Leukemia Research (7 papers) and Sarcoma Diagnosis and Treatment (4 papers). Marta Jeison collaborates with scholars based in Israel, United States and Canada. Marta Jeison's co-authors include Batia Stark, Isaac Yaniv, Shifra Ash, Rina Zaizov, Drorit Luria, Jerry Stein, Smadar Avigad, Ian J. Cohen, Yona Kodman and Yacov Goshen and has published in prestigious journals such as Blood, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Marta Jeison

20 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Jeison Israel 13 178 127 101 75 69 20 345
Chieko Homma Japan 7 219 1.2× 85 0.7× 52 0.5× 117 1.6× 51 0.7× 12 360
C. Grace United Kingdom 7 130 0.7× 160 1.3× 45 0.4× 72 1.0× 50 0.7× 11 352
Ester Rosenthal Israel 9 97 0.5× 128 1.0× 34 0.3× 34 0.5× 38 0.6× 13 324
Colin Grace United Kingdom 13 158 0.9× 252 2.0× 46 0.5× 59 0.8× 55 0.8× 20 463
Jinjun Cheng United States 10 171 1.0× 155 1.2× 87 0.9× 17 0.2× 78 1.1× 24 377
N Bown United Kingdom 10 275 1.5× 219 1.7× 95 0.9× 229 3.1× 122 1.8× 18 558
Susana Bizarro Portugal 12 165 0.9× 118 0.9× 66 0.7× 11 0.1× 40 0.6× 29 335
Ronald Lekanne dit Deprez Netherlands 3 117 0.7× 129 1.0× 17 0.2× 71 0.9× 50 0.7× 3 283
Eva Lumbreras Spain 10 146 0.8× 138 1.1× 42 0.4× 21 0.3× 18 0.3× 23 306
Hendrati Pirc‐Danoewinata Austria 13 219 1.2× 311 2.4× 50 0.5× 18 0.2× 146 2.1× 24 495

Countries citing papers authored by Marta Jeison

Since Specialization
Citations

This map shows the geographic impact of Marta Jeison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Jeison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Jeison more than expected).

Fields of papers citing papers by Marta Jeison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Jeison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Jeison. The network helps show where Marta Jeison may publish in the future.

Co-authorship network of co-authors of Marta Jeison

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Jeison. A scholar is included among the top collaborators of Marta Jeison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Jeison. Marta Jeison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dgany, Orly, Marta Jeison, Oded Gilad, et al.. (2020). Incorporation of somatic panels for the detection of haematopoietic transformation in children and young adults with leukaemia predisposition syndromes and with acquired cytopenias. British Journal of Haematology. 193(3). 570–580. 6 indexed citations
2.
Simon, Anthony, Atar Lev, Marta Jeison, et al.. (2013). Novel SMARCAL1 Bi-allelic Mutations Associated with a Chromosomal Breakage Phenotype in a Severe SIOD Patient. Journal of Clinical Immunology. 34(1). 76–83. 12 indexed citations
3.
Shichrur, Keren, Marta Jeison, Drorit Luria, et al.. (2013). miR-192 Directly Binds and Regulates Dicer1 Expression in Neuroblastoma. PLoS ONE. 8(11). e78713–e78713. 37 indexed citations
4.
5.
Jeison, Marta, Isaac Yaniv, & Shifra Ash. (2011). Genetic Stratification of Neuroblastoma for Treatment Tailoring. Future Oncology. 7(9). 1087–1099. 6 indexed citations
6.
Jeison, Marta, Shifra Ash, Drorit Luria, et al.. (2010). 2p24 Gain Region Harboring MYCN Gene Compared with MYCN Amplified and Nonamplified Neuroblastoma. American Journal Of Pathology. 176(6). 2616–2625. 26 indexed citations
7.
Avigad, Smadar, Marta Jeison, Drorit Luria, et al.. (2009). Reduced levels of miR‐34a in neuroblastoma are not caused by mutations in the TP53 binding site. Genes Chromosomes and Cancer. 48(7). 539–543. 26 indexed citations
8.
Avigad, Smadar, Drorit Luria, Marta Jeison, et al.. (2008). Minimal Residual Disease in Peripheral Blood Stem Cell Harvests From High-risk Neuroblastoma Patients. Journal of Pediatric Hematology/Oncology. 31(1). 22–26. 7 indexed citations
9.
Avigad, Smadar, Anat Ohali, Marta Jeison, et al.. (2007). Short Telomeres: A Novel Potential Predictor of Relapse in Ewing Sarcoma. Clinical Cancer Research. 13(19). 5777–5783. 29 indexed citations
10.
Stark, Batia, Marta Jeison, Drorit Luria, et al.. (2004). Classical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukaemia: report from a referral centre in Israel. British Journal of Haematology. 126(3). 320–337. 25 indexed citations
11.
Stark, Batia, Marta Jeison, Irit Bar‐Am, et al.. (2003). der(11)t(11;17): a distinct cytogenetic pathway of advanced stage neuroblastoma (NBL) – detected by spectral karyotyping (SKY). Cancer Letters. 197(1-2). 75–79. 12 indexed citations
12.
Stark, Batia, Marta Jeison, Irit Bar‐Am, et al.. (2002). Distinct cytogenetic pathways of advanced‐stage neuroblastoma tumors, detected by spectral karyotyping. Genes Chromosomes and Cancer. 34(3). 313–324. 12 indexed citations
13.
Stark, Batia, Marta Jeison, Claude Preudhomme, et al.. (2002). Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukaemia in young monozygotic twins. British Journal of Haematology. 118(4). 1082–1086. 13 indexed citations
14.
Stark, Batia, Marta Jeison, Drorit Luria, et al.. (2001). Near haploid childhood acute lymphoblastic leukemia masked by hyperdiploid line. Cancer Genetics and Cytogenetics. 128(2). 108–113. 35 indexed citations
15.
Stark, Batia, Marta Jeison, Shifra Ash, et al.. (2000). Apparently Unrelated Clones Shown by Spectral Karyotyping to Represent Clonal Evolution of Cryptic t(10;11)(p13;q23) in a Patient with Acute Monoblastic Leukemia. Cancer Genetics and Cytogenetics. 120(2). 105–110. 10 indexed citations
16.
Stark, Batia, Celia Mor, Marta Jeison, et al.. (1997). Additional chromosome 1q aberrations and der(16)t(1;16), correlation to the phenotypic expression and clinical behavior of the Ewing family of tumors. Journal of Neuro-Oncology. 31(1-2). 3–8. 16 indexed citations
17.
Stark, Batia, A. Zoubek, Claudia Maria Hattinger, et al.. (1996). Metastatic extraosseous Ewing tumor: Association of the additional translocation der(16)t(1;16) with the variant EWS/ERG rearrangement in a case of cytogenetically inconspicuous chromosome 22. Cancer Genetics and Cytogenetics. 87(2). 161–166. 9 indexed citations
18.
Stark, Batia, Marta Jeison, Drorit Luria, et al.. (1996). Dicentric (9;12) in pre-B acute lymphoblastic leukemia (ALL) in an infant.. PubMed. 10(1). 183–4. 4 indexed citations
19.
20.
Stark, Batia, Marta Jeison, Mordechai Shohat, et al.. (1994). Involvement of 11p15 and 3q21q26 in therapy-related myeloid leukemia (t-ML) in children. Cancer Genetics and Cytogenetics. 75(1). 11–22. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chieko Homma Breakdown of academic impact, for papers by C. Grace Breakdown of academic impact, for papers by Ester Rosenthal Breakdown of academic impact, for papers by Colin Grace Breakdown of academic impact, for papers by Jinjun Cheng Breakdown of academic impact, for papers by N Bown Breakdown of academic impact, for papers by Susana Bizarro Breakdown of academic impact, for papers by Ronald Lekanne dit Deprez Breakdown of academic impact, for papers by Eva Lumbreras Breakdown of academic impact, for papers by Hendrati Pirc‐Danoewinata
Rankless by CCL
2026